Cyberonics to Present at Maxim Group Growth Conference

• Press Release
• Source: Cyberonics, Inc.
• On 9:00 am EDT, Thursday September 17, 2009

HOUSTON, Sept. 17 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX - News) today announced that James Reinstein, Cyberonics' Vice President, Sales & Marketing and General Manager, International, will present at the Maxim Group Growth Conference in New York on Tuesday, September 29, 2009 at 2:30 PM EDT. Maxim will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/maxim2/cybx/. The replay will be available for 90 days following the conference. Presentation slides will be available on-line at www.cyberonics.com by 8:00 AM EDT on Tuesday, September 29, 2009. The presentation can also be accessed at www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (Nasdaq: CYBX - News) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at www.cyberonics.com and www.vnstherapy.com.

    CONTACT INFORMATION:
    Greg Browne, CFO
    Cyberonics, Inc.
    100 Cyberonics Blvd.
    Houston, TX 77058
    Main:  (281) 228-7262
    Fax:  (281) 218-9332
    ir@cyberonics.com

Buzz up!